134 related articles for article (PubMed ID: 3345515)
1. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
3. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
4. Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model.
Garg PK; Garg S; Bigner DD; Zalutsky MR
Cancer Res; 1992 Sep; 52(18):5054-60. PubMed ID: 1516061
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
[TBL] [Abstract][Full Text] [Related]
6. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
7. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
[TBL] [Abstract][Full Text] [Related]
9. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
10. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.
Cope DA; Dewhirst MW; Friedman HS; Bigner DD; Zalutsky MR
Cancer Res; 1990 Mar; 50(6):1803-9. PubMed ID: 2407344
[TBL] [Abstract][Full Text] [Related]
11. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
12. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.
Boskovitz A; Akabani GH; Pegram CN; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Apr; 31(3):345-55. PubMed ID: 15028247
[TBL] [Abstract][Full Text] [Related]
13. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
[TBL] [Abstract][Full Text] [Related]
14. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
[TBL] [Abstract][Full Text] [Related]
15. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
[TBL] [Abstract][Full Text] [Related]
16. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
Garg PK; Alston KL; Zalutsky MR
Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370
[TBL] [Abstract][Full Text] [Related]
17. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
19. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
Chen J; Strand SE; Sjögren HO
Cancer Biother Radiopharm; 1996 Jun; 11(3):217-26. PubMed ID: 10851540
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]